Read more at: Targeting hard-to-treat cancers
Targeting hard-to-treat cancers
17 October 2018
Cambridge leads a £10 million interdisciplinary collaboration to target the most challenging of cancers. We are going to pierce through the body’s natural barriers and deliver anti-cancer drugs to the heart of the tumour. George Malliaras While the survival rate for most cancers has doubled over the past 40 years, some...